217 related articles for article (PubMed ID: 31969822)
1. Microarray Expression Profiling and Raman Spectroscopy Reveal Anti-Fatty Liver Action of Berberine in a Diet-Induced Larval Zebrafish Model.
Chen B; Zheng YM; Zhang MQ; Han Y; Zhang JP; Hu CQ
Front Pharmacol; 2019; 10():1504. PubMed ID: 31969822
[No Abstract] [Full Text] [Related]
2. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
[TBL] [Abstract][Full Text] [Related]
3. Identification and Verification of Potential Therapeutic Target Genes in Berberine-Treated Zucker Diabetic Fatty Rats through Bioinformatics Analysis.
Wu YS; Chen YT; Bao YT; Li ZM; Zhou XJ; He JN; Dai SJ; Li CY
PLoS One; 2016; 11(11):e0166378. PubMed ID: 27846294
[TBL] [Abstract][Full Text] [Related]
4. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
5. Berberine attenuates hepatic oxidative stress in rats with non-alcoholic fatty liver disease via the Nrf2/ARE signalling pathway.
Deng Y; Tang K; Chen R; Nie H; Liang S; Zhang J; Zhang Y; Yang Q
Exp Ther Med; 2019 Mar; 17(3):2091-2098. PubMed ID: 30867696
[TBL] [Abstract][Full Text] [Related]
6. Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3.
Xu X; Zhu XP; Bai JY; Xia P; Li Y; Lu Y; Li XY; Gao X
FASEB J; 2019 Jun; 33(6):7289-7300. PubMed ID: 30848932
[TBL] [Abstract][Full Text] [Related]
7. Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles.
Yuan X; Wang J; Tang X; Li Y; Xia P; Gao X
J Transl Med; 2015 Jan; 13():24. PubMed ID: 25623289
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease.
Yan HM; Xia MF; Wang Y; Chang XX; Yao XZ; Rao SX; Zeng MS; Tu YF; Feng R; Jia WP; Liu J; Deng W; Jiang JD; Gao X
PLoS One; 2015; 10(8):e0134172. PubMed ID: 26252777
[TBL] [Abstract][Full Text] [Related]
9. High fat plus high cholesterol diet lead to hepatic steatosis in zebrafish larvae: a novel model for screening anti-hepatic steatosis drugs.
Dai W; Wang K; Zheng X; Chen X; Zhang W; Zhang Y; Hou J; Liu L
Nutr Metab (Lond); 2015; 12():42. PubMed ID: 26583037
[TBL] [Abstract][Full Text] [Related]
10. Berberine ameliorates fatty acid-induced oxidative stress in human hepatoma cells.
Sun Y; Yuan X; Zhang F; Han Y; Chang X; Xu X; Li Y; Gao X
Sci Rep; 2017 Sep; 7(1):11340. PubMed ID: 28900305
[TBL] [Abstract][Full Text] [Related]
11. Fructose leads to hepatic steatosis in zebrafish that is reversed by mechanistic target of rapamycin (mTOR) inhibition.
Sapp V; Gaffney L; EauClaire SF; Matthews RP
Hepatology; 2014 Nov; 60(5):1581-92. PubMed ID: 25043405
[TBL] [Abstract][Full Text] [Related]
12. Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress.
Zhang Z; Li B; Meng X; Yao S; Jin L; Yang J; Wang J; Zhang H; Zhang Z; Cai D; Zhang Y; Ning G
Sci Rep; 2016 Feb; 6():20848. PubMed ID: 26857750
[TBL] [Abstract][Full Text] [Related]
13. Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity.
Guo T; Woo SL; Guo X; Li H; Zheng J; Botchlett R; Liu M; Pei Y; Xu H; Cai Y; Zeng T; Chen L; Li X; Li Q; Xiao X; Huo Y; Wu C
Sci Rep; 2016 Mar; 6():22612. PubMed ID: 26936230
[TBL] [Abstract][Full Text] [Related]
14. ERK-dependent mTOR pathway is involved in berberine-induced autophagy in hepatic steatosis.
He Q; Mei D; Sha S; Fan S; Wang L; Dong M
J Mol Endocrinol; 2016 Nov; 57(4):251-260. PubMed ID: 27658958
[TBL] [Abstract][Full Text] [Related]
15. Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease
Yang S; Cao S; Li C; Zhang J; Liu C; Qiu F; Kang N
Front Pharmacol; 2022; 13():913378. PubMed ID: 35873595
[TBL] [Abstract][Full Text] [Related]
16. Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD.
Yang S; Cao SJ; Li CY; Zhang Q; Zhang BL; Qiu F; Kang N
J Ethnopharmacol; 2024 May; 332():118354. PubMed ID: 38762210
[TBL] [Abstract][Full Text] [Related]
17. Effects of berberine on growth, liver histology, and expression of lipid-related genes in blunt snout bream (Megalobrama amblycephala) fed high-fat diets.
Zhou W; Rahimnejad S; Lu K; Wang L; Liu W
Fish Physiol Biochem; 2019 Feb; 45(1):83-91. PubMed ID: 29984398
[TBL] [Abstract][Full Text] [Related]
18. Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3/AMPK/ACC Pathway.
Zhang YP; Deng YJ; Tang KR; Chen RS; Liang S; Liang YJ; Han L; Jin L; Liang ZE; Chen YN; Yang QH
Curr Med Sci; 2019 Feb; 39(1):37-43. PubMed ID: 30868489
[TBL] [Abstract][Full Text] [Related]
19. Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice.
Xue M; Zhang L; Yang MX; Zhang W; Li XM; Ou ZM; Li ZP; Liu SH; Li XJ; Yang SY
Int J Nanomedicine; 2015; 10():5049-57. PubMed ID: 26346310
[TBL] [Abstract][Full Text] [Related]
20. Kaempferol-3-O-Glucuronide Ameliorates Non-Alcoholic Steatohepatitis in High-Cholesterol-Diet-Induced Larval Zebrafish and HepG2 Cell Models via Regulating Oxidation Stress.
Deng Y; Ma J; Weng X; Wang Y; Li M; Yang T; Dou Z; Yin Z; Shang J
Life (Basel); 2021 May; 11(5):. PubMed ID: 34069176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
